Does Neurotropin-3 Have a Therapeutic Implication in Major Depression?

REFERENCES

• Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annual Review of Neuroscience 1995; 18: 223–253
   PubMed Web of Science ®Google Scholar
• Bourin M., David D. J., Jolliet P., Gardier A. Mechanism of action of antidepressants and therapeutic perspectives. Therapie 2002; 57(4)385–396
   Google Scholar
• Cavanaugh J. E., Ham J., Hetman M., Poser S., Yan C., Xia Z. Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons. Journal of Neuroscience 2001; 21(2)434–443
   PubMed Web of Science ®Google Scholar
• Celada P., Siuciak J. A., Tran T. M., Altar C. A., Tepper J. M. Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphe serotonergic neurons. Brain Research 1996; 712(2)293–298
   PubMed Web of Science ®Google Scholar
• Crown W. H., Finkelstein S., Berndt E. R., Ling D., Poret A. W., Rush A. J., et al. The impact of treatment-resistant depression on health care utilization and costs. The Journal of Clinical Psychiatry 2002; 63(11)963–971
   PubMed Web of Science ®Google Scholar
• Duman R. S. Pathophysiology of depression: The concept of synaptic plasticity. Euopeanr Psychiatry 2002; 17(Suppl. 3)S306–S310
   Google Scholar
• Faure J., Uys J. D., Marais L., Stein D. J., Daniels W. M. Early maternal separation followed by later stressors leads to dysregulation of the HPA-axis and increases in hippocampal NGF and NT-3 levels in a rat model. Metabolic Brain Disease 2006; 21(2–3)181–188
   PubMed Web of Science ®Google Scholar
• Fava M., Thase M. E., DeBattista C. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. The Journal of Clinical Psychiatry 2005; 66(1)85–93
   PubMed Web of Science ®Google Scholar
• Freeman A. Y., Pierce R. C. Neutralization of neutrophin-3 in the ventral tegmental area or nucleus accumbens differentially modulates cocaine-induced behavioral plasticity in rats. Synapse 2002; 46(2)57–65
   PubMed Web of Science ®Google Scholar
• Fumagalli F., Molteni R., Calabrese F., Frasca A., Racagni G., Riva M. A. Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. Journal of Neurochemistry 2005; 93(6)1551–1560
   Google Scholar
• Gratacos M., Soria V., Urretavizcaya M., Gonzalez J. R., Crespo J. M., Bayes M., et al. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. Pharmacogenomics Journal 2007; 8(2)101–112
   Google Scholar
• Hoshaw B. A., Malberg J. E., Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Research 2005; 1037(1–2)204–208
   PubMed Web of Science ®Google Scholar
• Huang T. L., Lee C. T., Liu Y. L. Serum brain-derived neurotrophic factor levels in patients with major depression: Effects of antidepressants. Journal of Psychiatric Research 2008; 42(7)521–525
   PubMed Web of Science ®Google Scholar
• Kempermann G., Kronenberg G. Depressed new neurons—Adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biological Psychiatry 2003; 54(5)499–503
   PubMed Web of Science ®Google Scholar
• Kushikata T., Kubota T., Fang J., Krueger J. M. Neurotrophins 3 and 4 enhance non-rapid eye movement sleep in rabbits. Neuroscience Letters 2003; 346(3)161–164
   Google Scholar
• Mamounas L. A., Blue M. E., Siuciak J. A., Altar C. A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. Journal of Neuroscience 1995; 15(12)7929–7939
   PubMed Web of Science ®Google Scholar
• Martin-Iverson M. T., Todd K. G., Altar C. A. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interactions with amphetamine. Journal of Neuroscience 1994; 14(3 Pt. 1)1262–1270
   PubMed Web of Science ®Google Scholar
• Nielsen D. M. Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?. Life Sciences 2006; 78(9)909–919
   PubMed Web of Science ®Google Scholar
• Paul J., Gottmann K., Lessmann V. NT-3 regulates BDNF-induced modulation of synaptic transmission in cultured hippocampal neurons. Neuroreport 2001; 12(12)2635–2639
   PubMed Web of Science ®Google Scholar
• Pierce R. C., Pierce-Bancroft A. F., Prasad B. M. Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade. Journal of Neuroscience 1999; 19(19)8685–8695
   PubMed Web of Science ®Google Scholar
• Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. Journal of Neuroscience 2003; 23(1)349–357
   PubMed Web of Science ®Google Scholar
• Sandi C., Bisaz R. A model for the involvement of neural cell adhesion molecules in stress-related mood disorders. Neuroendocrinology 2007; 85(3)158–176
   Google Scholar
• Schutte A., Yan Q., Mestres P., Giehl K. M. The endogenous survival promotion of axotomized rat corticospinal neurons by brain-derived neurotrophic factor is mediated via paracrine, rather than autocrine mechanisms. Neuroscience Letters 2000; 290(3)185–188
   PubMed Web of Science ®Google Scholar
• Sheline Y. I., Wang P. W., Gado M. H., Csernansky J. G., Vannier M. W. Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Sciences of the United States of America 1996; 93(9)3908–3913
   PubMed Web of Science ®Google Scholar
• Shimazu K., Zhao M., Sakata K., Akbarian S., Bates B., Jaenisch R., et al. NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis. Learning & Memory 2006; 13(3)307–315
   PubMed Web of Science ®Google Scholar
• Sieber-Blum M., Ren Z. Norepinephrine transporter expression and function in noradrenergic cell differentiation. Molecular and Cellular Biochemistry 2000; 212(1–2)61–70
   Google Scholar
• Siuciak J. A., Boylan C., Fritsche M., Altar C. A., Lindsay R. M. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Research 1996; 710(1–2)11–20
   PubMed Web of Science ®Google Scholar
• Smith M. A., Makino S., Altemus M., Michelson D., Hong S. K., Kvetnansky R., et al. Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proceedings of the National Academy of Sciences of the United States of America 1995; 92(19)8788–8792
   PubMed Web of Science ®Google Scholar
• Tardito D., Perez J., Tiraboschi E., Musazzi L., Racagni G., Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacological Reviews 2006; 58(1)115–134
   PubMed Web of Science ®Google Scholar
• Walz J. C., Frey B. N., Andreazza A. C., Cereser K. M., Cacilhas A. A., Valvassori S. S., et al. Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania. Journal of Psychiatric Research, in press
   Google Scholar